Quantitative proteomics reveals novel protein interaction partners of PP2A catalytic subunit in pancreatic β-cells

Molecular and Cellular Endocrinology

Volumn 424, Issue , 2016, Pages 1-11

  Zhang, Xiangmin ^a   Damacharla, Divyasri ^a   Ma, Danjun ^a   Qi, Yue ^a   Tagett, Rebecca ^b   Draghici, Sorin ^b   Kowluru, Anjaneyulu ^a,c   Yi, Zhengping ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b Wayne State University   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Glucotoxic condition; Interaction partner; Pancreatic cell; Quantitative proteomics; Serine threonine protein phosphatase 2A (PP2A)

Indexed keywords

GLUCOSE; INSULIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE 2;

APOPTOSIS; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INSULIN RELEASE; INTRACELLULAR SIGNALING; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; CELL CULTURE; GENE REGULATORY NETWORK; METABOLISM; PHYSIOLOGY; PROCEDURES; PROTEIN ANALYSIS;

CELLS, CULTURED; GENE REGULATORY NETWORKS; GLUCOSE; HUMANS; INSULIN-SECRETING CELLS; PROTEIN INTERACTION MAPPING; PROTEIN PHOSPHATASE 2; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84959206870     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2016.01.008     Document Type: Article

References (75)

1. Al-Hakim A.K., et al. 14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. J. Cell Sci. 2005, 118(Pt 23):5661-5673.
2. Arora D.K., et al. High glucose exposure promotes activation of protein phosphatase 2A in rodent islets and INS-1 832/13 β-cells by increasing the posttranslational carboxylmethylation of its catalytic subunit. Endocrinology 2014, 155(2):380-391.
3. Bernard O. Lim kinases, regulators of actin dynamics. Int. J. Biochem. Cell Biol. 2007, 39(6):1071-1076.
4. Caruso M., et al. Increased interaction with insulin receptor substrate 1, a novel abnormality in insulin resistance and type 2 diabetes. Diabetes 2014, 63(6):1933-1947.
5. Chandrashekarappa D.G., McCartney R.R., Schmidt M.C. Subunit and domain requirements for adenylate-mediated protection of Snf1 kinase activation loop from dephosphorylation. J. Biol. Chem. 2011, 286(52):44532-44541.
6. Chen J., Peterson R.T., Schreiber S.L. α4 associates with protein phosphatases 2A, 4, and 6. Biochem. Biophys. Res. Commun. 1998, 247(3):827-832.
7. Cheng A., et al. Biochemical characterization of Cdk2-Speedy/Ringo A2. BMC Biochem. 2005, 6:19.
8. Cheng A., Kaldis P., Solomon M.J. Dephosphorylation of human cyclin-dependent kinases by protein phosphatase type 2Cα and β2 isoforms. J. Biol. Chem. 2000, 275(44):34744-34749.
9. Chung H., et al. Mutation of Tyr307 and Leu309 in the protein phosphatase 2A catalytic subunit favors association with the α4 subunit which promotes dephosphorylation of elongation factor-2. Biochemistry 1999, 38(32):10371-10376.
10. Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008, 26(12):1367-1372.
11. Dehde S., et al. Two immunologically distinct human DNA polymerase α-primase subpopulations are involved in cellular DNA replication. Mol. Cell Biol. 2001, 21(7):2581-2593.
12. Dozier C., et al. Regulation of Chk2 phosphorylation by interaction with protein phosphatase 2A via its B' regulatory subunit. Biol. Cell 2004, 96(7):509-517.
13. Dubois T., et al. Identification of casein kinase Iα interacting protein partners. FEBS Lett. 2002, 517(1-3):167-171.
14. Ewing R.M., et al. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol. Syst. Biol. 2007, 3:89.
15. Fogeron M.L., et al. LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. Nat. Commun. 2013, 4:1531.
16. Geetha T., et al. Label-free proteomic identification of endogenous, insulin-stimulated interaction partners of insulin receptor substrate-1. J. Am. Soc. Mass Spectrom. 2011, 22(3):457-466.
17. Ghosh P., Kornfeld S. Phosphorylation-induced conformational changes regulate GGAs 1 and 3 function at the trans-Golgi network. J. Biol. Chem. 2003, 278(16):14543-14549.
18. Gingras A.C., et al. A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. Mol. Cell Proteom. 2005, 4(11):1725-1740.
19. Goudreault M., et al. A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Mol. Cell Proteom. 2009, 8(1):157-171.
20. Havugimana P.C., et al. A census of human soluble protein complexes. Cell 2012, 150(5):1068-1081.
21. + channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 2000, 49(3):424-430.
22. Honarpour N., et al. F-box protein FBXL16 binds PP2A-B55α and regulates differentiation of embryonic stem cells along the FLK1+ lineage. Mol. Cell Proteom. 2014, 13(3):780-791.
23. Hsu W., Zeng L., Costantini F. Identification of a domain of axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain. J. Biol. Chem. 1999, 274(6):3439-3445.
24. Hutchins J.R., et al. Systematic analysis of human protein complexes identifies chromosome segregation proteins. Science 2010, 328(5978):593-599.
25. Ito A., et al. A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation. EMBO J. 2000, 19(4):562-571.
26. Janssens V., Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 2001, 353(Pt 3):417-439.
27. Janssens V., Longin S., Goris J. PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends Biochem. Sci. 2008, 33(3):113-121.
28. Jimenez-Marin A., et al. Biological pathway analysis by ArrayUnlock and ingenuity pathway analysis. BMC Proc. 2009, 3(Suppl. 4):S6.
29. Jitrapakdee S., et al. Regulation of insulin secretion: role of mitochondrial signalling. Diabetologia 2010, 53(6):1019-1032.
30. Jones P.M., Persaud S.J. Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic β-cells. Endocr. Rev. 1998, 19(4):429-461.
31. Junttila M.R., et al. CIP2A inhibits PP2A in human malignancies. Cell 2007, 130(1):51-62.
32. Kamibayashi C., et al. Expression of the A subunit of protein phosphatase 2A and characterization of its interactions with the catalytic and regulatory subunits. J. Biol. Chem. 1992, 267(30):21864-21872.
33. Khadija S., et al. Glucotoxic and diabetic conditions induce caspase 6-mediated degradation of nuclear lamin A in human islets, rodent islets and INS-1 832/13 cells. Apoptosis 2014, 19(12):1691-1701.
34. Kong M., et al. α4 is an essential regulator of PP2A phosphatase activity. Mol. Cell 2009, 36(1):51-60.
35. Kowluru A. Novel regulatory roles for protein phosphatase-2A in the islet β cell. Biochem. Pharmacol. 2005, 69(12):1681-1691.
36. Kowluru A. Small G proteins in islet β-cell function. Endocr. Rev. 2010, 31(1):52-78.
37. Kowluru A., et al. Carboxylmethylation of the catalytic subunit of protein phosphatase 2A in insulin-secreting cells: evidence for functional consequences on enzyme activity and insulin secretion. Endocrinology 1996, 137(6):2315-2323.
38. Kowluru A., Matti A. Hyperactivation of protein phosphatase 2A in models of glucolipotoxicity and diabetes: potential mechanisms and functional consequences. Biochem. Pharmacol. 2012, 84(5):591-597.
39. Kristensen A.R., Gsponer J., Foster L.J. A high-throughput approach for measuring temporal changes in the interactome. Nat. Methods 2012, 9(9):907-909.
40. LeNoue-Newton M., et al. The E3 ubiquitin ligase- and protein phosphatase 2A (PP2A)-binding domains of the α4 protein are both required for α4 to inhibit PP2A degradation. J. Biol. Chem. 2011, 286(20):17665-17671.
41. Letourneux C., Rocher G., Porteu F. B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK. EMBO J. 2006, 25(4):727-738.
42. Liu J., et al. Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit α4. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(12):6650-6655.
43. Maeda K., et al. A new member of the α4-related molecule (α4-b) that binds to the protein phosphatase 2A is expressed selectively in the brain and testis. Eur. J. Biochem. 1999, 264(3):702-706.
44. Malovannaya A., et al. Streamlined analysis schema for high-throughput identification of endogenous protein complexes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(6):2431-2436.
45. Mandavia C., Sowers J.R. Phosphoprotein phosphatase PP2A regulation of insulin receptor substrate 1 and insulin metabolic signaling. Cardiorenal Med. 2012, 2(4):308-313.
46. Manetti F. LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators. Med. Res. Rev. 2012, 32(5):968-998.
47. Marcilla M., Albar J.P. Quantitative proteomics: a strategic ally to map protein interaction networks. IUBMB Life 2013, 65(1):9-16.
48. Martinez E., et al. Myocardium proteome remodelling after nutritional deprivation of methyl donors. J. Nutr. Biochem. 2013, 24(7):1241-1250.
49. McConnell J.L., et al. α4 is a ubiquitin-binding protein that regulates protein serine/threonine phosphatase 2A ubiquitination. Biochemistry 2010, 49(8):1713-1718.
50. McCright B., et al. The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. J. Biol. Chem. 1996, 271(36):22081-22089.
51. McDonald W.J., et al. α4 phosphoprotein interacts with EDD E3 ubiquitin ligase and poly(A)-binding protein. J. Cell Biochem. 2010, 110(5):1123-1129.
52. McDonald W.J., et al. Progestin-inducible EDD E3 ubiquitin ligase binds to α4 phosphoprotein to regulate ubiquitination and degradation of protein phosphatase PP2Ac. Mol. Cell Endocrinol. 2014, 382(1):254-261.
53. Millward T.A., Zolnierowicz S., Hemmings B.A. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 1999, 24(5):186-191.
54. Nazarenko I., Schafer R., Sers C. Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells. J. Cell Sci. 2007, 120(Pt 8):1393-1404.
55. Oberg E.A., et al. Selective proteasomal degradation of the B'ββ subunit of protein phosphatase 2A by the E3 ubiquitin ligase adaptor Kelch-like 15. J. Biol. Chem. 2012, 287(52):43378-43389.
56. Ohama T., Brautigan D.L. Endotoxin conditioning induces VCP/p97-mediated and inducible nitric-oxide synthase-dependent Tyr284 nitration in protein phosphatase 2A. J. Biol. Chem. 2010, 285(12):8711-8718.
57. Ortsater H., et al. Protein phosphatases in pancreatic islets. J. Endocrinol. 2014, 221(3):R121-R144.
58. Poitout V., Robertson R.P. Glucolipotoxicity: fuel excess and β-cell dysfunction. Endocr. Rev. 2008, 29(3):351-366.
59. Prentki M., Matschinsky F.M., Madiraju S.R. Metabolic signaling in fuel-induced insulin secretion. Cell Metab. 2013, 18(2):162-185.
60. Quevedo C., Salinas M., Alcazar A. Initiation factor 2B activity is regulated by protein phosphatase 1, which is activated by the mitogen-activated protein kinase-dependent pathway in insulin-like growth factor 1-stimulated neuronal cells. J. Biol. Chem. 2003, 278(19):16579-16586.
61. Sablina A.A., et al. The tumor suppressor PP2A Aβ regulates the RalA GTPase. Cell 2007, 129(5):969-982.
62. Scott R.W., Olson M.F. LIM kinases: function, regulation and association with human disease. J. Mol. Med. Berl. 2007, 85(6):555-568.
63. Sents W., et al. The biogenesis of active protein phosphatase 2A holoenzymes: a tightly regulated process creating phosphatase specificity. Febs J. 2013, 280(2):644-661.
64. Shamay M., et al. A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening. J. Virol. 2012, 86(9):5179-5191.
65. Syeda K., et al. Glucotoxic conditions induce endoplasmic reticulum stress to cause caspase 3 mediated lamin B degradation in pancreatic β-cells: protection by nifedipine. Biochem. Pharmacol. 2013, 86(9):1338-1346.
66. Veluthakal R., Wadzinski B.E., Kowluru A. Localization of a nuclear serine/threonine protein phosphatase in insulin-secreting INS-1 cells: potential regulation by IL-1β. Apoptosis 2006, 11(8):1401-1411.
67. Vera J., et al. Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor. Oncogene 2006, 25(2):260-270.
68. Vinayagam A., et al. A directed protein interaction network for investigating intracellular signal transduction. Sci. Signal 2011, 4(189):rs8.
69. Wang J., et al. Toward an understanding of the protein interaction network of the human liver. Mol. Syst. Biol. 2011, 7:536.
70. Wang Z., Thurmond D.C. Mechanisms of biphasic insulin-granule exocytosis - roles of the cytoskeleton, small GTPases and SNARE proteins. J. Cell Sci. 2009, 122(Pt 7):893-903.
71. Wepf A., et al. Quantitative interaction proteomics using mass spectrometry. Nat. Methods 2009, 6(3):203-205.
72. Yan Z., et al. PR48, a novel regulatory subunit of protein phosphatase 2A, interacts with Cdc6 and modulates DNA replication in human cells. Mol. Cell Biol. 2000, 20(3):1021-1029.
73. Yan L., et al. The B55α-containing PP2A holoenzyme dephosphorylates FOXO1 in islet β-cells under oxidative stress. Biochem. J. 2012, 444(2):239-247.
74. Zhou J., et al. Characterization of the Aα and Aβ subunit isoforms of protein phosphatase 2A: differences in expression, subunit interaction, and evolution. Biochem. J. 2003, 369(Pt 2):387-398.
75. Zwaenepoel K., et al. Protein phosphatase 2A PR130/B'α1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling. FASEB J. 2010, 24(2):538-547.